Ocugen to Spotlight Promising Gene Therapy in Clinical Showcase
MALVERN, PA — Ocugen, Inc. (NASDAQ: OCGN), a pioneer in the biotechnology field, is set to hold an in-person Clinical Showcase on February 21, 2024, at the Nasdaq Market Site …
Ocugen to Spotlight Promising Gene Therapy in Clinical Showcase Read More